Clinical Trial Update: The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation [NA]

View source ↗

Summary

A clinical trial comparison of edoxaban versus apixaban evaluating new brain lesions on MRI and safety in patients with stroke and nonvalvular atrial fibrillati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Eliquis (apixaban)
• Savaysa (edoxaban)

Snippet

Sponsor: Ewha Womans University Seoul Hospital | Conditions: Stroke, Atrial Fibrillation | NA | Status: NOT_YET_RECRUITING